Thursday August 16, 2018

FDA Approves Drug to Stop Some Malaria Relapses

Worldwide, malaria infects more than 200 million people a year and kills about half a million, most of them children in Africa

0
//
12
FDA
FILE - The GlaxoSmithKline offices in London. On Friday, the U.S. Food and Drug Administration approved GlaxoSmithKline’s Krintafel, a simpler, one-dose treatment, to prevent relapses of a type of malaria. (VOA)
Republish
Reprint

U.S. regulators Friday approved a simpler, one-dose treatment to prevent relapses of malaria.

Standard treatment now takes two weeks and studies show many patients don’t finish taking every dose.

Malaria is caused by parasites that are spread to people through mosquito bites. Anti-malarial drugs can cure the initial infection, but parasites can get into the liver, hide in a dormant form and cause recurrences months or years later. A second drug is used to stop relapses.

The new drug, GlaxoSmithKline’s Krintafel, only targets the kind of malaria that mainly occurs in South America and Southeast Asia. Most malaria cases and deaths are in Africa, and they involve another species.

In testing, one dose of Krintafel worked about the same as two weeks of the standard treatment, preventing relapses in about three-quarters of patients in six months, the company said.

Malaria is caused by parasites that are spread to people through mosquito bites.
Malaria is caused by parasites that are spread to people through mosquito bites. (VOA)

The Food and Drug Administration approved the drug for patients 16 and older, according to GlaxoSmithKline. The company said it’s the first new treatment in six decades for preventing relapses.

GlaxoSmithKline plans to apply soon for approval in Brazil, then other countries where the malaria type is common. It says it will sell the pills at low cost in poor countries.

Millions infected worldwide

Worldwide, malaria infects more than 200 million people a year and kills about half a million, most of them children in Africa. It causes fever, headache, chills and other flulike symptoms. The malaria type Krintafel targets causes about 8.5 million infections annually.

Also Read: Trial Wipes out More Than 80 per cent of Disease-Spreading Mosquitoes

The British drugmaker, working with the World Health Organization, is also developing what could be the world’s first malaria vaccine, but early testing indicates it’s not very effective. Prevention now focuses on using insecticides and bed nets. (VOA)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

New Type of Bed Net Could Help Fight Against Malaria

The latest figures from the World Health Organisation shows that in 2016 malaria infected about 216 million people across 91 countries, up from five million in 2015

0
Malaria
This new type of bed net can help prevent malaria: Lancet. (VOA)

Researchers have developed a new type of bed net with a specific combination of an insecticide and insect growth regulator that could prevent millions of cases of malaria.

The novel net, detailed in the journal The Lancet, contains a pyrethroid insecticide, which repels and kills the mosquitoes, and an insect growth regulator — pyriproxyfen — which shortens the lives of mosquitoes and reduces their ability to reproduce.

Compared to conventional nets, this new type of mosquito net reduced the number of cases of clinical malaria by 12 per cent.

In areas with new combination beds, there was also a 51 per cent reduction in risk of a malaria infective mosquito bite.

Children sleeping under the new bed nets were 52 per cent less likely to be moderately anaemic, which is a major cause of mortality in children under two years, the research showed.

Malaria
Compared to conventional nets, this new type of mosquito net reduced the number of cases of clinical malaria by 12 per cent. Pixabay

“This new invaluable tool would enable us to tackle more efficiently this terrible and deadly disease that affects many children. If deployed correctly, we could certainly prevent millions of cases and deaths of malaria,” said principal investigator Alfred B. Tiono, from the CNRFP in Africa.

For the study, the team conducted a two-year clinical trial in Burkina Faso, West Africa, involving 2,000 children, aged between six months and five years.

In the trial, the conventional bed nets were replaced over time with the new combination nets in 40 rural clusters covering 91 villages, involving 1,980 children in 2014 and 2,157 in 2015.

You May Also Like to Read About an Autoimmune Disease: Study Suggests Glaucoma May be an Autoimmune Disease

The number of mosquito bites and incidence of clinical malaria in the participants were recorded by health clinics and the number of mosquitoes in the houses was tracked through monthly light traps.

The latest figures from the World Health Organisation shows that in 2016 malaria infected about 216 million people across 91 countries, up from five million in 2015. (IANS)